Trust Stamp makes first LLM-focused AI Patent filing for Medical Diagnosis Assurance
Rhea-AI Summary
Trust Stamp (Nasdaq: IDAI) filed a U.S. provisional patent on June 15, 2026 for its first LLM-focused AI invention, the Medical Diagnostic Assurance System (MDAS). The company now has twenty seven issued or allowed patents and seven pending.
MDAS is designed to reduce confirmation bias, hallucinations, and sycophantic behavior in medical diagnosis. It uses tokenized patient identities, a three-model consensus that does not issue primary diagnoses, and aims to support qualified practitioners. A pilot is under negotiation, with a target go-live in Q1 2027.
Positive
- None.
Negative
- None.
Market reaction after MDAS AI patent filing: IDAI +10.40% in the Jul 2 session
In the Jul 2 session, IDAI gained 10.40%, reflecting a significant positive market reaction. Argus tracked a peak move of +13.2% during that session. Our momentum scanner triggered 19 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous AI Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 01 | Sovereign-AI project win | Positive | +2.0% | Delivered a custom Sovereign-LLM project and set AI strategy shareholder call. |
| Oct 24 | AI patent allowance | Positive | +3.7% | USPTO notice of allowance for Generative AI‑related multifactor authentication patent. |
| Mar 25 | Biometric anti-deepfake patent | Positive | -5.1% | USPTO allowance for liveness detection patent targeting deepfake and injection attacks. |
| Aug 07 | AI licensing agreement | Positive | +23.9% | Licensed AI tech for hydrogen-powered drones, generating $5M Q3 2024 income. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent AI-tagged news has usually drawn a positive price reaction, with one notable selloff on otherwise constructive patent news.
Key Terms
llm technical
confirmation bias technical
tokenization technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Atlanta, GA, July 02, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) Gareth N. Genner, Chief Executive Officer of the Company commented, “Prior to this we had a total of twenty seven issued or allowed patents and seven patents pending, covering a range of proprietary technologies encompassing AI, Biometrics and cryptography. On June 15, 2026 we filed U.S. Provisional Patent Application No. 64/091,057 entitled: “Medical Diagnostic Assurance System” (“MDAS”) for an LLM-based technology designed to avoid critical issues in medical diagnosis including confirmation bias amplification, and hallucinations that could cite invented data sources.
"Sycophantic behavior can undermine the reliability of LLM outputs in any use case, but in medical diagnosis, the consequences can be catastrophic. MDAS is intended to operate as a self-contained sovereign system with tokenization of patient identities, thereby protecting patient records from third-party access, for use only by qualified medical practitioners. MDAS does not provide a primary diagnosis but, using a three-model consensus, challenges and/or reinforces the medical practitioner’s diagnosis using data flows that ensure that the model’s research is conducted blind to that original diagnosis.
We are currently negotiating a pilot program for MDAS and aim to have the technology live in Q1 of 2027.”
Inquiries:
Trust Stamp Email: Shareholders@truststamp.ai
About Trust Stamp
Trust Stamp is a global provider of AI-powered services for use in multiple sectors including banking and finance, regulatory compliance, government, healthcare, real estate, communications, and humanitarian services. Its technology empowers organizations via advanced solutions that reduce fraud, tokenize and secure data, securely authenticate users while protecting personal privacy, reduce friction in digital transactions, and increase operational efficiency, enabling customers to accelerate secure financial inclusion and reach and serve a broader base of users worldwide.
With team members from twenty-two nationalities in eight countries across North America, Europe, Asia, and Africa, Trust Stamp trades on the Nasdaq Capital Market (Nasdaq: IDAI).
Safe Harbor Statement: Caution Concerning Forward-Looking Remarks
All statements in this release that are not based on historical fact are “forward-looking statements” including within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The information in this announcement may contain forward-looking statements and information related to, among other things, the company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events-based information currently available and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.
